Literature DB >> 18349037

Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit.

M J Sweeting1, D De Angelis, M Hickman, A E Ades.   

Abstract

Multiparameter evidence synthesis is becoming widely used as a way of combining evidence from multiple and often disparate sources of information concerning a number of parameters. Synthesizing data in one encompassing model allows propagation of evidence and learning. We demonstrate the use of such an approach in estimating the number of people infected with the hepatitis C virus (HCV) in England and Wales. Data are obtained from seroprevalence studies conducted in different subpopulations. Each subpopulation is modeled as a composition of 3 main HCV risk groups (current injecting drug users (IDUs), ex-IDUs, and non-IDUs). Further, data obtained on the prevalence (size) of each risk group provide an estimate of the prevalence of HCV in the whole population. We simultaneously estimate all model parameters through the use of Bayesian Markov chain Monte Carlo techniques. The main emphasis of this paper is the assessment of evidence consistency and investigation of the main drivers for model inferences. We consider a cross-validation technique to reveal data conflict and leverage when each data source is in turn removed from the model.

Entities:  

Mesh:

Year:  2008        PMID: 18349037     DOI: 10.1093/biostatistics/kxn004

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  8 in total

1.  Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups.

Authors:  Annunziata Faustini; Paola Colais; Emanuele Fabrizi; Anna Maria Bargagli; Marina Davoli; Domenico Di Lallo; Anteo Di Napoli; Patrizio Pezzotti; Chiara Sorge; Rita Grillo; Carla Maresca; Olga Recchia; Carlo A Perucci
Journal:  BMC Infect Dis       Date:  2010-04-19       Impact factor: 3.090

2.  The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controls.

Authors:  John Macleod; Lorraine Copeland; Matthew Hickman; James McKenzie; Jo Kimber; Daniela De Angelis; James R Robertson
Journal:  BMC Public Health       Date:  2010-02-26       Impact factor: 3.295

3.  New methodology for estimating the burden of infectious diseases in Europe.

Authors:  Mirjam Kretzschmar; Marie-Josée J Mangen; Paulo Pinheiro; Beate Jahn; Eric M Fèvre; Silvia Longhi; Taavi Lai; Arie H Havelaar; Claudia Stein; Alessandro Cassini; Piotr Kramarz
Journal:  PLoS Med       Date:  2012-04-17       Impact factor: 11.069

4.  Evidence synthesis for decision making 5: the baseline natural history model.

Authors:  Sofia Dias; Nicky J Welton; Alex J Sutton; A E Ades
Journal:  Med Decis Making       Date:  2013-07       Impact factor: 2.583

5.  Bayesian evidence synthesis to estimate HIV prevalence in men who have sex with men in Poland at the end of 2009.

Authors:  M Rosinska; P Gwiazda; D De Angelis; A M Presanis
Journal:  Epidemiol Infect       Date:  2015-11-06       Impact factor: 2.451

6.  Monitoring the hepatitis C epidemic in England and evaluating intervention scale-up using routinely collected data.

Authors:  Ross J Harris; Helen E Harris; Sema Mandal; Mary Ramsay; Peter Vickerman; Matthew Hickman; Daniela De Angelis
Journal:  J Viral Hepat       Date:  2019-02-28       Impact factor: 3.728

7.  An evidence synthesis approach for combining different data sources illustrated using entomological efficacy of insecticides for indoor residual spraying.

Authors:  Nathan Green; Fiacre Agossa; Boulais Yovogan; Richard Oxborough; Jovin Kitau; Pie Müller; Edi Constant; Mark Rowland; Emile F S Tchacaya; Koudou G Benjamin; Thomas S Churcher; Michael Betancourt; Ellie Sherrard-Smith
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

8.  Fully Bayesian hierarchical modelling in two stages, with application to meta-analysis.

Authors:  David Lunn; Jessica Barrett; Michael Sweeting; Simon Thompson
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2013-08       Impact factor: 1.864

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.